Sleep physiology features from wearable trackers predict next-day physical fatigue in healthy adults with moderate discriminative capacity
The study evaluated the feasibility of using consumer- and research-grade sleep trackers to predict next-day fatigue and sleepiness in individuals with neurodegenerative and immune-mediated inflammatory diseases. In healthy adults, machine learning models achieved an AUC of 0.75 for predicting next-day physical fatigue, with respiratory rate and REM sleep duration as key features. Predictive performance was lower in chronic disease cohorts (AUC 0.62 for physical fatigue in NDD).
Evidence Score
Study Evidence
Study 1. Exploring the feasibility of modeling next-day fatigue and sleepiness using digital sleep tracker data in neurodegenerative and immune-mediated inflammatory diseases.
observationalZhai B, Chen L, Ma X, Pinaud C, Chatterjee M, Kortelainen JM, Rehman RZU, Ahmaniemi T, Avey S, Guan Y, Macrae V, Hinchliffe C, Del Din S, Manyakov NV, Göder R, Romijnders R, Maetzler W, Reilmann R, Aufenberg S, Schubert R, van der Woude CJ, Zhang D, Ng WF ยท Frontiers in digital health (2026)
Result:
Mechanism Graph
Limitations
- โ Outcome binarisation using a global threshold may conflate between-person disease-group differences with within-person symptom variation
- โ Predictive performance in chronic disease cohorts remains limited, underscoring the need for larger, multimodal studies
- โ Findings are exploratory and not confirmatory
Frequently Asked Questions
What sleep features were most predictive of next-day fatigue?โผ
Respiratory rate and REM sleep duration were the key drivers for predicting physical fatigue in healthy adults. In neurodegenerative disease, REM latency and deep sleep were important features.
How accurate were the sleep trackers compared to polysomnography?โผ
The sleep trackers showed moderate agreement with polysomnography in a sub-study of 28 participants.
Can these findings be applied to people with chronic diseases?โผ
Predictive performance was limited in neurodegenerative and immune-mediated inflammatory disease cohorts (AUC โค 0.66), so the findings are not yet clinically applicable to these populations.
What is the main limitation of this study?โผ
The binarisation of fatigue outcomes using a global threshold may mix between-person differences with within-person variation, and the study is exploratory without definitive clinical recommendations.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Zhai B, Chen L, Ma X, Pinaud C, Chatterjee M, Kortelainen JM, Rehman RZU, Ahmaniemi T, Avey S, Guan Y, Macrae V, Hinchliffe C, Del Din S, Manyakov NV, Göder R, Romijnders R, Maetzler W, Reilmann R, Aufenberg S, Schubert R, van der Woude CJ, Zhang D, Ng WF. "Exploring the feasibility of modeling next-day fatigue and sleepiness using digital sleep tracker data in neurodegenerative and immune-mediated inflammatory diseases.." Frontiers in digital health, 2026. PMID: 42388291 DOI: 10.3389/fdgth.2026.1752629